Daiichi Sankyo, coming off a successful trip to Madrid that included a mega deal and a data drop to set the record straight on its next ADC candidate’s safety, is setting up for a lucrative few years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,